Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Calithera Biosciences logo — Targeting cancer, differently.

Calithera Biosciences

Targeting cancer, differently.

Founded 2010 United States South San Francisco, United States 27 employees Post-IPO Equity Biotechnology, Health and Wellness +1

General Information

Company Name Calithera Biosciences
Founded Year 2010
Location United States South San Francisco, United States
Founders / Decision Makers
Team member Team member
Employees 27
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Calithera Biosciences. To contact Calithera Biosciences, visit calithera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Calithera Biosciences compare?

A PDF of Calithera Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Calithera Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Calithera Biosciences

Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially starve tumor cells and enhance immune-cell activity. The company, founded in 2010, is committed to rigorous science and has a passion for improving the lives of people impacted by cancer and other life-threatening diseases. Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients in the biotechnology, health and wellness, and pharmaceutical industries. The company is headquartered in the United States. Its last investment, a Post-IPO Equity investment, took place on 30 March 2022. However, specific information about the investors involved in this round is not available. With its focus on targeting cancer differently, Calithera Biosciences presents an intriguing opportunity for potential venture capital interest.

Business keywords: biopharmaceuticals, clinical-stage, targeted therapies, metabolic pathways, immune-cell activity, oral therapeutics, small molecule therapeutics, cancer treatment, scientific expertise, pipeline development, novel anti-cancer drugs

No funding data available for Calithera Biosciences yet.

Calithera Biosciences Alternatives & Competitors

View All Alternatives
Calithera Biosciences vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
Calithera Biosciences vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care
Calithera Biosciences vs
Compass Therapeutics Inc.
Compass Therapeutics Inc. United States

We are developing next-generation antibodies into transformative cancer therapies that improve patie...

IPO
57 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Calithera Biosciences

Targeting cancer, differently.
Calithera Biosciences was founded in 2010.
Calithera Biosciences is headquartered in South San Francisco, United States.
Calithera Biosciences operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceuticals, clinical-stage, targeted therapies and metabolic pathways.
Calithera Biosciences has approximately 27 employees.
Top alternatives and competitors to Calithera Biosciences include Prescient Therapeutics, Apollomics, Compass Therapeutics Inc., 2seventy bio, Tango Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Calithera Biosciences and Prescient Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Calithera Biosciences, https://bouncewatch.com/company/calithera-biosciences, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout